Inhibition of Oxidative Stress and Related Signaling Pathways in Neuroprotection

Maja Jazvinšćak Jembrek1,2

  • 1Division of Molecular Medicine, Ruđer Bošković Institute, Bijenička 54, 10000 Zagreb, Croatia.

PubMed

Insights

Oxidative stress contributes to neurodegeneration by increasing reactive oxygen species (ROS) and disrupting redox balance, leading to synaptic loss and neuronal death in brain diseases.

Area of Science:

  • Neuroscience
  • Biochemistry
  • Pathology

Background:

  • Oxidative stress, marked by elevated reactive oxygen species (ROS) and impaired redox homeostasis, is a critical factor in neurodegenerative diseases.
  • This imbalance contributes significantly to synaptic dysfunction and neuronal apoptosis.

Discussion:

  • The study investigates the intricate relationship between oxidative stress markers and neurodegeneration.
  • Understanding these mechanisms is crucial for developing targeted therapeutic strategies.

Key Insights:

  • Oxidative stress is a central player in the pathogenesis of neurodegenerative conditions.
  • ROS accumulation directly correlates with synaptic loss and neuronal cell death.

Outlook:

  • Further research into antioxidant therapies could mitigate neurodegenerative processes.
  • Developing interventions that restore redox balance may offer new treatment avenues.

Related Concept Videos

Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
12.1K
The Blood-brain Barrier00:49

The Blood-brain Barrier

Overview
47.0K
Drugs Affecting Neurotransmitter Synthesis01:29

Drugs Affecting Neurotransmitter Synthesis

Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
1.3K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.2K